It is worth noting that some studies did not observe any change in the frequency of Tregs (CD4+ CD25+ FoxP3+) in the peripheral blood of COVID-19 patients 67, 68, including in cancer patients infected with SARS-CoV-2 69. This evidence concerns the gene FOXP3 and COVID-19.